StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the stock. Separately, HC Wainwright cut their target price on shares of Can-Fite BioPharma from $34.00 to $18.00 and set a “buy” rating for the company in a […]
StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research note released on Monday. The firm issued a hold rating on the stock. Separately, HC Wainwright lowered their price objective on Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating for the company in a research report on […]
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright cut their target price on Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating on the stock in a research report on […]
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright cut their price target on shares of Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating on the stock in a report […]
Can-Fite BioPharma (NYSE:CANF – Get Free Report) announced its earnings results on Thursday. The company reported ($0.43) EPS for the quarter, hitting the consensus estimate of ($0.43), reports. Can-Fite BioPharma had a negative net margin of 1,146.62% and a negative return on equity of 136.11%. The company had revenue of $0.20 million for the quarter, […]